Success Stories: An Indian Manager in Biotechnologies Wins NIW Approval in Just 27 Days, Credit Goes to Our Team’s Efforts, and the Premium Processing Upgrade
Client’s Testimonial:
“Thank you so much for all your help.”
On February 14th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Manager in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnologies
Position at the Time of Case Filing: Manager
Country of Origin: India
State of Residence at the Time of Filing: Florida
Approval Notice Date: February 14th, 2023
Processing Time: 27 days (Premium Processing Requested)
Case Summary:
The success of any case depends on how well the application is construed and how air-tight the arguments are. Any client of ours who wishes to get a National Interest Waiver application approved goes through a rigorous scrutiny process before the petition writing stage. Only after determining the value of their work do we suggest they move forward with the application. This was the case with our Indian client, a manager in biotechnologies. Holding a Ph.D. in the area, he wanted to continue his research on using biotechnological principles to analyze the interaction of viruses, and drug therapies in order to improve public health.
So, we concluded that his research endeavor is of great importance because it contributes to the development of novel methods for analyzing and addressing major diseases on a global scale. Not only this but his proposed endeavor also has broad implications for the United States as his ongoing work in the field of biotechnologies has proven invaluable for the interest of the United States, particularly in terms of developing new methods to remediate major health concerns such as HIV, and Zika virus. Each of these conditions has a profound and deleterious impact on public health and wellness in the United States. Due to this clear national importance, his research was supported with funding from the National Institutes of Health.
Academically too he has been engaged in publishing articles and conducting peer reviews. He has completed at least 14 reviews to date and has published his work in 6 peer-reviewed journal articles (3 of them first-authored) which have been cited a total of 136 times according to Google Scholar. Thus his 7 years of work have been very fruitful for the national and international markets. This value was recognized by experts who wrote letters of recommendation for him supporting his work.
So, when his approval came through in just 27 days, we were very happy to share the burden and credit of the approval. The short adjudication period was also due to the premium processing upgrade that he had chosen. Our firm takes this opportunity to wish him success and happiness in the future.